Atlas Trials

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide

Clinical trial NCT00806013 · COMPLETED

Trial details

NCT number
NCT00806013
Sponsor
Chinese Academy of Sciences
Status
COMPLETED
Study type
OBSERVATIONAL
Healthy
Start date
2008-08-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.